niacinamide has been researched along with Lymphoma, Non-Hodgkin in 7 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinolinic acid utilization was the most intense in the kidney of rats with Walker's carcinosarcoma while nicotinic acid and nicotinamide were mostly utilized in the kidney of rats with lymphosarcoma of Pliss." | 1.29 | [Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors]. ( Filov, VA; Ivin, BA; Kon'kov, SA; Krylova, IM; Reztsova, VV, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cichocki, F | 1 |
| Zhang, B | 1 |
| Wu, CY | 1 |
| Chiu, E | 1 |
| Day, A | 1 |
| O'Connor, RS | 1 |
| Yackoubov, D | 1 |
| Simantov, R | 1 |
| McKenna, DH | 1 |
| Cao, Q | 1 |
| Defor, TE | 1 |
| Janakiram, M | 1 |
| Wangen, R | 1 |
| Cayci, Z | 1 |
| Snyder, N | 1 |
| Kumar, A | 1 |
| Grzywacz, B | 1 |
| Hwang, J | 1 |
| Geffen, Y | 1 |
| Miller, JS | 1 |
| Maakaron, J | 1 |
| Bachanova, V | 1 |
| Al-Katib, A | 1 |
| Arnold, AA | 1 |
| Aboukameel, A | 1 |
| Sosin, A | 1 |
| Smith, P | 1 |
| Mohamed, AN | 1 |
| Beck, FW | 1 |
| Mohammad, RM | 1 |
| Chapuy, B | 1 |
| Schuelper, N | 1 |
| Panse, M | 1 |
| Dohm, A | 1 |
| Hand, E | 1 |
| Schroers, R | 1 |
| Truemper, L | 1 |
| Wulf, GG | 1 |
| Ramakrishnan, V | 1 |
| Timm, M | 1 |
| Haug, JL | 1 |
| Kimlinger, TK | 1 |
| Halling, T | 1 |
| Wellik, LE | 1 |
| Witzig, TE | 1 |
| Rajkumar, SV | 1 |
| Adjei, AA | 1 |
| Kumar, S | 1 |
| ALTENBRUNN, HJ | 1 |
| STEENBECK, L | 1 |
| EHRHARDT, E | 1 |
| SCHMAGLOWSKI, S | 1 |
| Reztsova, VV | 2 |
| Filov, VA | 2 |
| Ivin, BA | 1 |
| Kon'kov, SA | 1 |
| Krylova, IM | 1 |
7 other studies available for niacinamide and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.
Topics: Humans; Interleukin-15; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Niacinamide; Rituximab | 2023 |
I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma.
Topics: Animals; Antitussive Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cyclophosph | 2010 |
Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Cell Cycle; Cell Death; Cell Proliferation; Dos | 2011 |
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Cell Line, Tumor; Drug | 2012 |
[INVESTIGATION ON THE DECREASE IN CONCENTRATION OF NAD IN LYMPHOSARCOMA ASCITES CELLS FOLLOWING X-IRRADIATION].
Topics: Ascites; Chromatography; Lymphoma; Lymphoma, Non-Hodgkin; Metabolism; NAD; Neoplasms; Neoplasms, Exp | 1965 |
[Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors].
Topics: Animals; Carcinoma 256, Walker; Enzyme Precursors; Kidney; Liver; Lymphoma, Non-Hodgkin; NAD; Neopla | 1994 |
[Effect of glucose and glutamine on the intensity of NAD precursor use in rats with transplanted tumors].
Topics: Animals; Carcinoma 256, Walker; Glucose; Glutamine; Kidney; Liver; Lymphoma, Non-Hodgkin; NAD; Neopl | 1995 |